EP2946206
Mat, greiningar og meðhöndlun á pKal-miðluðum röskunum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.1.2014EP published:
9.1.2019EP application number:
14740167.3
EP translation filed:
3.4.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
16.1.2034Expiry date:
16.1.2027Next due date:
31.1.2027
Title:
EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERS
Timeline
Today
17.1.2014EP application
9.1.2019EP Publication
3.4.2019Translation submitted
15.4.2019Registration published
16.1.2027Expires
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, JP
Inventor
Name:
JOSEPH, KusumamAddress:
Mt. Pleasant, SC, US
Name:
KAPLAN, Allen, P.Address:
Charleston, SC, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201361754600 PDate:
20.1.2013Country:
US
Classification
Categories:
G01N 33/48, G01N 33/50, C12Q 1/56
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 7.3.2019
Expires: 16.1.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 7
Paid: 18.12.2019
Expires: 16.1.2021
Payer: Ólafur Ragnarsson hrl.
Number: 8
Paid: 17.12.2020
Expires: 16.1.2022
Payer: Patice ehf.
Number: 9
Paid: 15.12.2021
Expires: 16.1.2023
Payer: Patice ehf.
Number: 10
Paid: 22.12.2022
Expires: 16.1.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 20.12.2023
Expires: 16.1.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 27.12.2024
Expires: 16.1.2026
Payer: Árnason Faktor ehf.
Number: 13
Paid: 12.1.2026
Expires: 16.1.2027
Payer: Árnason Faktor ehf.